CT-ADE: An Evaluation Benchmark for Adverse Drug Event Prediction from Clinical Trial Results

• URL: http://arxiv.org/abs/2404.12827v2
• Date: Tue, 30 Jul 2024 08:38:50 GMT
• Title: CT-ADE: An Evaluation Benchmark for Adverse Drug Event Prediction from Clinical Trial Results
• Authors: Anthony Yazdani, Alban Bornet, Philipp Khlebnikov, Boya Zhang, Hossein Rouhizadeh, Poorya Amini, Douglas Teodoro,
• Abstract summary: Adverse drug events (ADEs) significantly impact clinical research, causing many clinical trial failures. To support this effort, we introduce CT-ADE, a dataset for multilabel predictive modeling of ADEs in monopharmacy treatments. CT-ADE integrates data from 2,497 unique drugs, encompassing 168,984 drug-ADE pairs extracted from clinical trials, annotated with patient and contextual information, and comprehensive ADE concepts standardized across multiple levels of the MedDRA.
• Score: 0.10051474951635876
• License: http://creativecommons.org/licenses/by/4.0/
• Abstract: Adverse drug events (ADEs) significantly impact clinical research, causing many clinical trial failures. ADE prediction is key for developing safer medications and enhancing patient outcomes. To support this effort, we introduce CT-ADE, a dataset for multilabel predictive modeling of ADEs in monopharmacy treatments. CT-ADE integrates data from 2,497 unique drugs, encompassing 168,984 drug-ADE pairs extracted from clinical trials, annotated with patient and contextual information, and comprehensive ADE concepts standardized across multiple levels of the MedDRA ontology. Preliminary analyses with large language models (LLMs) achieved F1-scores up to 55.90%. Models using patient and contextual information showed F1-score improvements of 21%-38% over models using only chemical structure data. Our results highlight the importance of target population and treatment regimens in the predictive modeling of ADEs, offering greater performance gains than LLM domain specialization and scaling. CT-ADE provides an essential tool for researchers aiming to leverage artificial intelligence and machine learning to enhance patient safety and minimize the impact of ADEs on pharmaceutical research and development. The dataset is publicly accessible at https://github.com/ds4dh/CT-ADE.

Related papers

• Enhancing End Stage Renal Disease Outcome Prediction: A Multi-Sourced Data-Driven Approach [7.212939068975618]
  We utilized data about 10,326 CKD patients, combining their clinical and claims information from 2009 to 2018. A 24-month observation window was identified as optimal for balancing early detection and prediction accuracy. The 2021 eGFR equation improved prediction accuracy and reduced racial bias, notably for African American patients.
  arXiv  Detail & Related papers  (2024-10-02T03:21:01Z)
• TrialBench: Multi-Modal Artificial Intelligence-Ready Clinical Trial Datasets [57.067409211231244]
  This paper presents meticulously curated AIready datasets covering multi-modal data (e.g., drug molecule, disease code, text, categorical/numerical features) and 8 crucial prediction challenges in clinical trial design. We provide basic validation methods for each task to ensure the datasets' usability and reliability. We anticipate that the availability of such open-access datasets will catalyze the development of advanced AI approaches for clinical trial design.
  arXiv  Detail & Related papers  (2024-06-30T09:13:10Z)
• Physical formula enhanced multi-task learning for pharmacokinetics prediction [54.13787789006417]
  A major challenge for AI-driven drug discovery is the scarcity of high-quality data. We develop a formula enhanced mul-ti-task learning (PEMAL) method that predicts four key parameters of pharmacokinetics simultaneously. Our experiments reveal that PEMAL significantly lowers the data demand, compared to typical Graph Neural Networks.
  arXiv  Detail & Related papers  (2024-04-16T07:42:55Z)
• Enhancing Acute Kidney Injury Prediction through Integration of Drug Features in Intensive Care Units [0.0]
  The relationship between acute kidney injury (AKI) prediction and nephrotoxic drugs has yet to be explored in the critical care setting. This study proposes a novel approach that leverages patient prescription data as a modality to improve existing models for AKI prediction.
  arXiv  Detail & Related papers  (2024-01-09T05:42:32Z)
• MedDiffusion: Boosting Health Risk Prediction via Diffusion-based Data Augmentation [58.93221876843639]
  This paper introduces a novel, end-to-end diffusion-based risk prediction model, named MedDiffusion. It enhances risk prediction performance by creating synthetic patient data during training to enlarge sample space. It discerns hidden relationships between patient visits using a step-wise attention mechanism, enabling the model to automatically retain the most vital information for generating high-quality data.
  arXiv  Detail & Related papers  (2023-10-04T01:36:30Z)
• TREEMENT: Interpretable Patient-Trial Matching via Personalized Dynamic Tree-Based Memory Network [54.332862955411656]
  Clinical trials are critical for drug development but often suffer from expensive and inefficient patient recruitment. In recent years, machine learning models have been proposed for speeding up patient recruitment via automatically matching patients with clinical trials. We introduce a dynamic tree-based memory network model named TREEMENT to provide accurate and interpretable patient trial matching.
  arXiv  Detail & Related papers  (2023-07-19T12:35:09Z)
• Prediction of drug effectiveness in rheumatoid arthritis patients based on machine learning algorithms [2.5759046095742453]
  Rheumatoid arthritis (RA) is an autoimmune condition caused when patients' immune system mistakenly targets their own tissue. Machine learning (ML) has the potential to identify patterns in patient electronic health records to forecast the best clinical treatment to improve patient outcomes. This study introduced a Drug Response Prediction (TNF) framework with two main goals: 1) design a data processing pipeline to extract information from clinical data, and then preprocess it for functional use, and 2) predict RA patient's responses to drugs and evaluate classification models' performance.
  arXiv  Detail & Related papers  (2022-10-14T15:15:37Z)
• Literature-Augmented Clinical Outcome Prediction [10.46990394710927]
  We introduce techniques to help bridge this gap between EBM and AI-based clinical models. We propose a novel system that automatically retrieves patient-specific literature based on intensive care (ICU) patient information. Our model is able to substantially boost predictive accuracy on three challenging tasks in comparison to strong recent baselines.
  arXiv  Detail & Related papers  (2021-11-16T11:19:02Z)
• Bootstrapping Your Own Positive Sample: Contrastive Learning With Electronic Health Record Data [62.29031007761901]
  This paper proposes a novel contrastive regularized clinical classification model. We introduce two unique positive sampling strategies specifically tailored for EHR data. Our framework yields highly competitive experimental results in predicting the mortality risk on real-world COVID-19 EHR data.
  arXiv  Detail & Related papers  (2021-04-07T06:02:04Z)
• HINT: Hierarchical Interaction Network for Trial Outcome Prediction Leveraging Web Data [56.53715632642495]
  Clinical trials face uncertain outcomes due to issues with efficacy, safety, or problems with patient recruitment. In this paper, we propose Hierarchical INteraction Network (HINT) for more general, clinical trial outcome predictions.
  arXiv  Detail & Related papers  (2021-02-08T15:09:07Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.